Global Pediatric Digestive Drugs 麻豆原创 Growth (Status and Outlook) 2025-2031

Publication ID:

LPI02254159

Publication Date:

February 27, 2025

Pages:

131

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Pediatric Digestive Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for Pediatric Digestive Drugs is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Pediatric Digestive Drugs is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Pediatric Digestive Drugs is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Pediatric Digestive Drugs players cover AstraZeneca, Sanofi, Aptalis, Eisai, Pfizer, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淧ediatric Digestive Drugs Industry Forecast鈥� looks at past sales and reviews total world Pediatric Digestive Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Pediatric Digestive Drugs sales for 2025 through 2031. With Pediatric Digestive Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pediatric Digestive Drugs industry.
This Insight Report provides a comprehensive analysis of the global Pediatric Digestive Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Pediatric Digestive Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Pediatric Digestive Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pediatric Digestive Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pediatric Digestive Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Pediatric Digestive Drugs market by product type, application, key players and key regions and countries.
Segmentation by Type:
Tablets
Pills
Oral Liquid
Segmentation by Application:
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
AstraZeneca
Sanofi
Aptalis
Eisai
Pfizer
Zeria (Tillotts)
GlaxoSmithKline
Salix Pharmaceuticals
Perrigo
Abbott
Honz Pharmaceutical
Shandong DYNE Marine Biopharmaceutical
Sunflower Pharmaceutical
Jiangzhong Pharmaceutical
Yabao Pharmaceutical
Jumpcan Pharmaceutical
Hansen Pharmaceutical

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Pediatric Digestive Drugs 麻豆原创 Size (2020-2031)
2.1.2 Pediatric Digestive Drugs 麻豆原创 Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Pediatric Digestive Drugs by Country/Region (2020, 2024 & 2031)
2.2 Pediatric Digestive Drugs Segment by Type
2.2.1 Tablets
2.2.2 Pills
2.2.3 Oral Liquid
2.3 Pediatric Digestive Drugs 麻豆原创 Size by Type
2.3.1 Pediatric Digestive Drugs 麻豆原创 Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Pediatric Digestive Drugs 麻豆原创 Size 麻豆原创 Share by Type (2020-2025)
2.4 Pediatric Digestive Drugs Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Online Pharmacies
2.4.3 Retail Pharmacies
2.5 Pediatric Digestive Drugs 麻豆原创 Size by Application
2.5.1 Pediatric Digestive Drugs 麻豆原创 Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Pediatric Digestive Drugs 麻豆原创 Size 麻豆原创 Share by Application (2020-2025)
3 Pediatric Digestive Drugs 麻豆原创 Size by Player
3.1 Pediatric Digestive Drugs 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Pediatric Digestive Drugs Revenue by Player (2020-2025)
3.1.2 Global Pediatric Digestive Drugs Revenue 麻豆原创 Share by Player (2020-2025)
3.2 Global Pediatric Digestive Drugs Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Pediatric Digestive Drugs by Region
4.1 Pediatric Digestive Drugs 麻豆原创 Size by Region (2020-2025)
4.2 Global Pediatric Digestive Drugs Annual Revenue by Country/Region (2020-2025)
4.3 Americas Pediatric Digestive Drugs 麻豆原创 Size Growth (2020-2025)
4.4 APAC Pediatric Digestive Drugs 麻豆原创 Size Growth (2020-2025)
4.5 Europe Pediatric Digestive Drugs 麻豆原创 Size Growth (2020-2025)
4.6 Middle East & Africa Pediatric Digestive Drugs 麻豆原创 Size Growth (2020-2025)
5 Americas
5.1 Americas Pediatric Digestive Drugs 麻豆原创 Size by Country (2020-2025)
5.2 Americas Pediatric Digestive Drugs 麻豆原创 Size by Type (2020-2025)
5.3 Americas Pediatric Digestive Drugs 麻豆原创 Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pediatric Digestive Drugs 麻豆原创 Size by Region (2020-2025)
6.2 APAC Pediatric Digestive Drugs 麻豆原创 Size by Type (2020-2025)
6.3 APAC Pediatric Digestive Drugs 麻豆原创 Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Pediatric Digestive Drugs 麻豆原创 Size by Country (2020-2025)
7.2 Europe Pediatric Digestive Drugs 麻豆原创 Size by Type (2020-2025)
7.3 Europe Pediatric Digestive Drugs 麻豆原创 Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pediatric Digestive Drugs by Region (2020-2025)
8.2 Middle East & Africa Pediatric Digestive Drugs 麻豆原创 Size by Type (2020-2025)
8.3 Middle East & Africa Pediatric Digestive Drugs 麻豆原创 Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Pediatric Digestive Drugs 麻豆原创 Forecast
10.1 Global Pediatric Digestive Drugs Forecast by Region (2026-2031)
10.1.1 Global Pediatric Digestive Drugs Forecast by Region (2026-2031)
10.1.2 Americas Pediatric Digestive Drugs Forecast
10.1.3 APAC Pediatric Digestive Drugs Forecast
10.1.4 Europe Pediatric Digestive Drugs Forecast
10.1.5 Middle East & Africa Pediatric Digestive Drugs Forecast
10.2 Americas Pediatric Digestive Drugs Forecast by Country (2026-2031)
10.2.1 United States 麻豆原创 Pediatric Digestive Drugs Forecast
10.2.2 Canada 麻豆原创 Pediatric Digestive Drugs Forecast
10.2.3 Mexico 麻豆原创 Pediatric Digestive Drugs Forecast
10.2.4 Brazil 麻豆原创 Pediatric Digestive Drugs Forecast
10.3 APAC Pediatric Digestive Drugs Forecast by Region (2026-2031)
10.3.1 China Pediatric Digestive Drugs 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Pediatric Digestive Drugs Forecast
10.3.3 Korea 麻豆原创 Pediatric Digestive Drugs Forecast
10.3.4 Southeast Asia 麻豆原创 Pediatric Digestive Drugs Forecast
10.3.5 India 麻豆原创 Pediatric Digestive Drugs Forecast
10.3.6 Australia 麻豆原创 Pediatric Digestive Drugs Forecast
10.4 Europe Pediatric Digestive Drugs Forecast by Country (2026-2031)
10.4.1 Germany 麻豆原创 Pediatric Digestive Drugs Forecast
10.4.2 France 麻豆原创 Pediatric Digestive Drugs Forecast
10.4.3 UK 麻豆原创 Pediatric Digestive Drugs Forecast
10.4.4 Italy 麻豆原创 Pediatric Digestive Drugs Forecast
10.4.5 Russia 麻豆原创 Pediatric Digestive Drugs Forecast
10.5 Middle East & Africa Pediatric Digestive Drugs Forecast by Region (2026-2031)
10.5.1 Egypt 麻豆原创 Pediatric Digestive Drugs Forecast
10.5.2 South Africa 麻豆原创 Pediatric Digestive Drugs Forecast
10.5.3 Israel 麻豆原创 Pediatric Digestive Drugs Forecast
10.5.4 Turkey 麻豆原创 Pediatric Digestive Drugs Forecast
10.6 Global Pediatric Digestive Drugs Forecast by Type (2026-2031)
10.7 Global Pediatric Digestive Drugs Forecast by Application (2026-2031)
10.7.1 GCC Countries 麻豆原创 Pediatric Digestive Drugs Forecast
11 Key Players Analysis
11.1 AstraZeneca
11.1.1 AstraZeneca Company Information
11.1.2 AstraZeneca Pediatric Digestive Drugs Product Offered
11.1.3 AstraZeneca Pediatric Digestive Drugs Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.1.4 AstraZeneca Main Business Overview
11.1.5 AstraZeneca Latest Developments
11.2 Sanofi
11.2.1 Sanofi Company Information
11.2.2 Sanofi Pediatric Digestive Drugs Product Offered
11.2.3 Sanofi Pediatric Digestive Drugs Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.2.4 Sanofi Main Business Overview
11.2.5 Sanofi Latest Developments
11.3 Aptalis
11.3.1 Aptalis Company Information
11.3.2 Aptalis Pediatric Digestive Drugs Product Offered
11.3.3 Aptalis Pediatric Digestive Drugs Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.3.4 Aptalis Main Business Overview
11.3.5 Aptalis Latest Developments
11.4 Eisai
11.4.1 Eisai Company Information
11.4.2 Eisai Pediatric Digestive Drugs Product Offered
11.4.3 Eisai Pediatric Digestive Drugs Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.4.4 Eisai Main Business Overview
11.4.5 Eisai Latest Developments
11.5 Pfizer
11.5.1 Pfizer Company Information
11.5.2 Pfizer Pediatric Digestive Drugs Product Offered
11.5.3 Pfizer Pediatric Digestive Drugs Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.5.4 Pfizer Main Business Overview
11.5.5 Pfizer Latest Developments
11.6 Zeria (Tillotts)
11.6.1 Zeria (Tillotts) Company Information
11.6.2 Zeria (Tillotts) Pediatric Digestive Drugs Product Offered
11.6.3 Zeria (Tillotts) Pediatric Digestive Drugs Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.6.4 Zeria (Tillotts) Main Business Overview
11.6.5 Zeria (Tillotts) Latest Developments
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Information
11.7.2 GlaxoSmithKline Pediatric Digestive Drugs Product Offered
11.7.3 GlaxoSmithKline Pediatric Digestive Drugs Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.7.4 GlaxoSmithKline Main Business Overview
11.7.5 GlaxoSmithKline Latest Developments
11.8 Salix Pharmaceuticals
11.8.1 Salix Pharmaceuticals Company Information
11.8.2 Salix Pharmaceuticals Pediatric Digestive Drugs Product Offered
11.8.3 Salix Pharmaceuticals Pediatric Digestive Drugs Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.8.4 Salix Pharmaceuticals Main Business Overview
11.8.5 Salix Pharmaceuticals Latest Developments
11.9 Perrigo
11.9.1 Perrigo Company Information
11.9.2 Perrigo Pediatric Digestive Drugs Product Offered
11.9.3 Perrigo Pediatric Digestive Drugs Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.9.4 Perrigo Main Business Overview
11.9.5 Perrigo Latest Developments
11.10 Abbott
11.10.1 Abbott Company Information
11.10.2 Abbott Pediatric Digestive Drugs Product Offered
11.10.3 Abbott Pediatric Digestive Drugs Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.10.4 Abbott Main Business Overview
11.10.5 Abbott Latest Developments
11.11 Honz Pharmaceutical
11.11.1 Honz Pharmaceutical Company Information
11.11.2 Honz Pharmaceutical Pediatric Digestive Drugs Product Offered
11.11.3 Honz Pharmaceutical Pediatric Digestive Drugs Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.11.4 Honz Pharmaceutical Main Business Overview
11.11.5 Honz Pharmaceutical Latest Developments
11.12 Shandong DYNE Marine Biopharmaceutical
11.12.1 Shandong DYNE Marine Biopharmaceutical Company Information
11.12.2 Shandong DYNE Marine Biopharmaceutical Pediatric Digestive Drugs Product Offered
11.12.3 Shandong DYNE Marine Biopharmaceutical Pediatric Digestive Drugs Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.12.4 Shandong DYNE Marine Biopharmaceutical Main Business Overview
11.12.5 Shandong DYNE Marine Biopharmaceutical Latest Developments
11.13 Sunflower Pharmaceutical
11.13.1 Sunflower Pharmaceutical Company Information
11.13.2 Sunflower Pharmaceutical Pediatric Digestive Drugs Product Offered
11.13.3 Sunflower Pharmaceutical Pediatric Digestive Drugs Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.13.4 Sunflower Pharmaceutical Main Business Overview
11.13.5 Sunflower Pharmaceutical Latest Developments
11.14 Jiangzhong Pharmaceutical
11.14.1 Jiangzhong Pharmaceutical Company Information
11.14.2 Jiangzhong Pharmaceutical Pediatric Digestive Drugs Product Offered
11.14.3 Jiangzhong Pharmaceutical Pediatric Digestive Drugs Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.14.4 Jiangzhong Pharmaceutical Main Business Overview
11.14.5 Jiangzhong Pharmaceutical Latest Developments
11.15 Yabao Pharmaceutical
11.15.1 Yabao Pharmaceutical Company Information
11.15.2 Yabao Pharmaceutical Pediatric Digestive Drugs Product Offered
11.15.3 Yabao Pharmaceutical Pediatric Digestive Drugs Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.15.4 Yabao Pharmaceutical Main Business Overview
11.15.5 Yabao Pharmaceutical Latest Developments
11.16 Jumpcan Pharmaceutical
11.16.1 Jumpcan Pharmaceutical Company Information
11.16.2 Jumpcan Pharmaceutical Pediatric Digestive Drugs Product Offered
11.16.3 Jumpcan Pharmaceutical Pediatric Digestive Drugs Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.16.4 Jumpcan Pharmaceutical Main Business Overview
11.16.5 Jumpcan Pharmaceutical Latest Developments
11.17 Hansen Pharmaceutical
11.17.1 Hansen Pharmaceutical Company Information
11.17.2 Hansen Pharmaceutical Pediatric Digestive Drugs Product Offered
11.17.3 Hansen Pharmaceutical Pediatric Digestive Drugs Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.17.4 Hansen Pharmaceutical Main Business Overview
11.17.5 Hansen Pharmaceutical Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.